Jan Moller Mikkelsen
President, CEO, Member of Executive Board & Executive DirectorMr. Jan Moller Mikkelsen is President, CEO, Member of Executive Board & Executive Director of Ascendis Pharma A/S from December 2007. He joined the Ascendis Pharma A/S in December 2007. He was Chairman of the Board of Hummingbird Bioscience Pte. Ltd. from November 2021 to August 2026. He was Non-Executive Director of VISEN Pharmaceuticals (Shanghai) Co., Ltd since March 27, 2021 until July 2025 and served as its Director since November 07, 2018. He had been Non-Executive Director at VISEN Pharmaceuticals since November 7, 2018 until June 27, 2025. He is Senior Advisor of Frazier Life Sciences Management, LP. He joined the Frazier Life Sciences Management, LP in 2022. He is Director of Eyconis, Inc. He is Senior Advisor of Frazier Management, L.L.C. He joined the Frazier Management, L.L.C. in 2022. He was Senior Advisor of Vivo Capital, LLC until 2021. He was employed at Vivo Capital, LLC until 2021. He focused on United states. He was Director of Nuevolution AB (publ). He was President and Chief Executive Officer of Veloxis Pharmaceuticals A/S. He was Unit President of Maxygen, Inc. He was Managing Director of Maxygen ApS. He was Chairman of HyScite Discovery. He was Member of Advisory Team of NB Capital ApS. He was Director of Protein Discovery of Novo Nordisk A/S. He has M.S. in Biochemistry from Syddansk Universitet.
Positions
- Company NameAscendis Pharma A/SStock CodeASNDPositionPresident, CEO, Member of Executive Board & Executive DirectorColleagues
- ACAlbert ChaIndependent Chairman
- STScott T. SmithCFO, Executive VP & Member of Executive Board
- PAPedersen Anni Lotte Kirstine SonderbjergExecutive VP, Chief Administrative Officer & Member of the Executive Board
- MWMichael Wolff JensenExecutive VP, Chief Legal Officer & Member of the Executive Board
- MBMads BodenhoffSenior VP, Head of Finance & Principal Accounting Officer
- LHLars HoltugIndependent Director
- LBLisa Bright MorrisonIndependent Director
- SISiham ImaniIndependent Director
